Elanco Animal Health
Price & Volume
Stats
See more52W Range | $8.02-$24.47 |
Market Cap | $12.1B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $4.5B |
Revenue Growth (YoY) | 10.4% |
Gross Profit (12 Mos) | $2.5B |
Diluted EPS | $0.07 |
News
See moreYahoo Finance • 14 days ago
Elanco gaisn approval of Befrena for canine dermatitis
Yahoo Finance • 24 days ago
Jim Cramer on Elanco Animal Health: “They Are Doing Everything Right”
Yahoo Finance • 27 days ago
Elanco Receives FDA Conditional Approval For Credelio Quattro CA1 To Treat Screwworm In Dogs
Yahoo Finance • 28 days ago
Elanco (ELAN): Valuation Check After Insider Buying Spree and New Restructuring Plan
About
CEO | Mr. Jeffrey N. Simmons |
CFO | Mr. Robert M. VanHimbergen |
Address | 2500 Innovation Way, Greenfield, IN, United States, 46140 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 9,000 |
